Everolimus-Treated Renal Transplant Recipients Have a More Robust CMV-Specific CD8+ T-Cell Response Compared With Cyclosporine- or Mycophenolate-Treated Patients-Reference-Cited by-同舟云学术

Everolimus-Treated Renal Transplant Recipients Have a More Robust CMV-Specific CD8+ T-Cell Response Compared With Cyclosporine- or Mycophenolate-Treated Patients

Published:2013-01-15 Issue:1 Volume:95 Page:184-191
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Havenith Simone H.C.,Yong Si La,van Donselaar-van der Pant Karlijn A.M.I.,van Lier René A.W.,ten Berge Ineke J.M.,Bemelman Fréderike J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference28 articles.

1. Immunosuppressive drugs for kidney transplantation.;Halloran;N Engl J Med,2004

2. . Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control.;Loewith;Mol Cell,2002

3. . Comparative transcriptional and phenotypic peripheral blood analysis of kidney recipients under cyclosporin A or sirolimus monotherapy.;Brouard;Am J Transplant,2010

4. Rapamycin selectively expands CD4CD25FoxP3 regulatory T cells.;Battaglia;Blood,2005

5. . De novo induction of antigen-specific CD4CD25Foxp3 regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR.;Kang;J Leukoc Biol,2008

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Posttransplant complications: molecular mechanisms and therapeutic interventions;MedComm;2024-09

2. The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients;Kidney International Reports;2024-06

3. Human cytomegalovirus‐related gastrointestinal disease after kidney transplantation: A systematic review;Clinical Transplantation;2023-12-08

4. Anti-CMV therapy, what next? A systematic review;Frontiers in Microbiology;2023-11-20

5. Recurrent Cytomegalovirus Infection Controlled by the Introduction of Everolimus in a Simultaneous Pancreas-Kidney Transplantation Recipient: A Case Report;Transplantation Proceedings;2022-07